Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123093) titled 'A real-world study on the efficacy and safety of Xuesaitong soft capsule monotherapy vs. conventional antiplatelet therapy for ischemic stroke' on April 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Dongfang Hospital, Beijing University of Chinese Medicine; Xuanwu Hospital, Capital Medical University
Condition:
ischemic stroke
Intervention:
Observation group (treated with Xuesaitong Soft Capsules as monotherapy):None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2023-11-01
Target Sample Size: Observation group (treated with Xu...